About Zuellig Pharma
Zuellig Pharma is a company based in Singapore (Singapore) founded in 1992. It operates as a B2B2C, and Managed Services. Zuellig Pharma has completed 4 acquisitions, including Alliance Pharma Cambodge, Klinify and MiCare. Zuellig Pharma offers products and services including eZRx+, Clinical Trial Support, and Patient Care Solutions. Zuellig Pharma operates in a competitive market with competitors including Indegene, IntegriChain, Clinigen, Fabtech and Science Group, among others.
- Headquarter Singapore, Singapore
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Zuellig Pharma Holdings
- Date of Incorporation 02 Mar, 2015
- Jurisdiction Bhiwandi, Maharashtra, India
-
Annual Revenue
$610.02 K (USD)-31.96as on Mar 31, 2022
-
Net Profit
$66.94 K (USD)-25.45as on Mar 31, 2022
-
EBITDA
$87.6 K (USD)-39.61as on Mar 31, 2022
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
Alliance Pharma Cambodge
& 3 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Zuellig Pharma
Zuellig Pharma offers a comprehensive portfolio of products and services, including eZRx+, Clinical Trial Support, and Patient Care Solutions. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
B2B healthcare platform launched for efficient distribution solutions.
Support for clinical trials with advanced logistics infrastructure.
Digital solutions prioritizing patient safety and healthcare management.
Unlock access to complete
Funding Insights of Zuellig Pharma
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2007 | Amount | Unspecified - Zuellig Pharma | Valuation | Temasek |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Zuellig Pharma
Zuellig Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Temasek. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
An investment platform is provided for diverse sectors and geographies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Zuellig Pharma
Zuellig Pharma has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Alliance Pharma Cambodge, Klinify and MiCare. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Patient records are managed through a cloud-based platform for clinics.
|
2011 | ||||
|
Third-party administration services are provided in Malaysia.
|
2006 | ||||
|
Pharmaceutical products are distributed and stored in Cambodia.
|
2001 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Zuellig Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Zuellig Pharma Comparisons
Competitors of Zuellig Pharma
Zuellig Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, IntegriChain, Clinigen, Fabtech and Science Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Suite solutions are provided for payers and healthcare providers.
|
|
| domain | founded_year | HQ Location |
Inventory, order and customer relationship management solution for life science suppliers.
|
|
| domain | founded_year | HQ Location |
Specialty medicines are supplied via clinical trials and access programs.
|
|
| domain | founded_year | HQ Location |
Instruments for biotech, pharmaceutical, and biomedical sectors are manufactured.
|
|
| domain | founded_year | HQ Location |
Technology-based consultancy and product development services are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Zuellig Pharma
Frequently Asked Questions about Zuellig Pharma
When was Zuellig Pharma founded?
Zuellig Pharma was founded in 1992 and raised its 1st funding round 15 years after it was founded.
Where is Zuellig Pharma located?
Zuellig Pharma is headquartered in Singapore, Singapore.
Who is the current CEO of Zuellig Pharma?
John Graham is the current CEO of Zuellig Pharma.
What is the annual revenue of Zuellig Pharma?
Annual revenue of Zuellig Pharma is $610.02K as on Mar 31, 2022.
What does Zuellig Pharma do?
Healthcare access across Asia is facilitated by Zuellig Pharma through integrated solutions. The company operates in pharmaceuticals, medical devices, consumer healthcare, vaccines, animal health, and specialty care. Innovative distribution, commercialization, clinical trial support, and patient care solutions are provided. Partnerships with manufacturers, governments, and healthcare providers are leveraged to expand reach. State-of-the-art technology and logistics, including cold chain solutions, are utilized to bridge healthcare gaps in 13 markets.
Who are the top competitors of Zuellig Pharma?
Zuellig Pharma's top competitors include Indegene, IntegriChain and Clinigen.
What products or services does Zuellig Pharma offer?
Zuellig Pharma offers eZRx+, Clinical Trial Support, and Patient Care Solutions.
How many acquisitions has Zuellig Pharma made?
Zuellig Pharma has made 4 acquisitions, including Alliance Pharma Cambodge, Klinify, and MiCare.
Who are Zuellig Pharma's investors?
Zuellig Pharma has 1 investor. Key investors include Temasek.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.